SOBECKI CHRISTOPHER J
SEC insider (Form 3/4/5 filer). CIK 0001053892. Director at LEXICON PHARMACEUTICALS, INC. (LXRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in THE WOODLANDS, TX.
Companies SOBECKI CHRISTOPHER J has filed insider reports for
- LEXICON PHARMACEUTICALS, INC. (LXRX): Director
SOBECKI CHRISTOPHER J
CIK: 0001053892
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXICON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 3, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect89.3K shares- - May 1, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
35.7K shares- - May 1, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
43.5K shares- - Jun 3, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
103.8K shares- - Jun 3, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
89.3K shares- - May 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect36.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 89,312 | - | $0 | Direct |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 35,714 | - | - | Direct |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 43,478 | - | - | Direct |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 103,806 | - | - | Direct |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 89,312 | - | - | Direct |
| May 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 36,810 | - | - | Direct |
1-6 of 6 transactions